Clinical Immunology Department, University Hospital La Paz, Madrid, Spain.
Lymphocyte Pathophysiology in Immunodeficiencies Group, La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Front Immunol. 2024 Oct 24;15:1479472. doi: 10.3389/fimmu.2024.1479472. eCollection 2024.
Epstein-Barr virus (EBV) specific T-cell response measurement can help adjust immunosuppression in transplant patients with persistent infections. We aim to define T-cell responses against EBV in a cohort of pediatric liver-transplant patients.
Thirty-eight immunosuppressed pediatric liver-transplant patients (IP) and 25 EBV-seropositive healthy-adult controls (HC) were included in our cross-sectional study. Based on their EBV serological (S) and viral load (VL) status, patients were categorized into IP-S, IP-SVL and IP-SVL groups. T-cell response was assessed at two timepoints by stimulating cells with EBV peptides (PepTivator) and performing intracellular-cytokine and activation-induced marker staining. Background subtraction was used to determine EBV-specific T-lymphocyte frequency.
Polyfunctional CD8+ T cells indicated previous EBV contact (IP-S 0.00% vs IP-S 0.04% and HC 0.02%; p=0.001 and p=0.01, respectively). Polyfunctional CD8+CD107a+IFNɣ+IL2-TNFα- profile was increased in serology-positive (IP-S 0.01% vs IP-S 0.13% and HC 0.03%; p=0.01 and p=0.50, respectively) and viral-load positive (IP-SVL 0.43% vs IP-SVL 0.07% and HC 0.03%; p=0.03 and p=0.001, respectively) patients. Central-memory cells were increased among serology-positive adults (IP-S 0.00% vs IP-S 0.13% and HC 4.33%; p=0.58 and p=0.002, respectively). At the second timepoint, IP-S patients remained negative (first visit 0.01% vs second visit 0.00%, p=0.44). On the other hand, IP-SVL patients had cleared viral loads and, subsequently, decreased polyfunctional CD8+CD107a+IFNɣ+IL2-TNFα- cells (first visit 0.43% vs second visit 0.10%, p=0.81).
Polyfunctional CD8+ EBV-specific T-cell response allows detecting EBV previous contact in liver-transplant children. %CD8+CD107a+IFNɣ+IL2-TNFα- is increased in patients with positive viral loads. Central memory CD4+ T-cell population more effectively determines prior EBV-exposure in adults.
Epstein-Barr 病毒 (EBV) 特异性 T 细胞反应的测量有助于调整持续性感染的移植患者的免疫抑制。我们旨在确定一组儿科肝移植患者的 EBV 特异性 T 细胞反应。
我们的横断面研究纳入了 38 名免疫抑制的儿科肝移植患者 (IP) 和 25 名 EBV 血清阳性的健康成人对照 (HC)。根据他们的 EBV 血清学 (S) 和病毒载量 (VL) 状态,患者被分为 IP-S、IP-SVL 和 IP-SVL 组。通过用 EBV 肽 (PepTivator) 刺激细胞并进行细胞内细胞因子和激活诱导标志物染色,在两个时间点评估 T 细胞反应。使用背景扣除来确定 EBV 特异性 T 淋巴细胞的频率。
多能性 CD8+ T 细胞表明之前接触过 EBV (IP-S 0.00% vs IP-S 0.04% 和 HC 0.02%;p=0.001 和 p=0.01,分别)。在血清学阳性患者中,多能性 CD8+CD107a+IFNɣ+IL2-TNFα- 谱增加(IP-S 0.01% vs IP-S 0.13% 和 HC 0.03%;p=0.01 和 p=0.50,分别)和病毒载量阳性患者(IP-SVL 0.43% vs IP-SVL 0.07% 和 HC 0.03%;p=0.03 和 p=0.001,分别)。血清学阳性成人的中央记忆细胞增加(IP-S 0.00% vs IP-S 0.13% 和 HC 4.33%;p=0.58 和 p=0.002,分别)。在第二个时间点,IP-S 患者仍然为阴性(首次就诊 0.01% vs 第二次就诊 0.00%,p=0.44)。另一方面,IP-SVL 患者清除了病毒载量,随后减少了多能性 CD8+CD107a+IFNɣ+IL2-TNFα-细胞(首次就诊 0.43% vs 第二次就诊 0.10%,p=0.81)。
多能性 CD8+ EBV 特异性 T 细胞反应可检测肝移植儿童中 EBV 之前的接触。%CD8+CD107a+IFNɣ+IL2-TNFα-在病毒载量阳性患者中增加。中央记忆 CD4+ T 细胞群体更有效地确定成人中之前的 EBV 暴露。